Maternal Serum sEndoglin and Cell-Free Fetal DNA as Probable Markers of Preeclampsia: A Study in Single Center, Egypt

References

• Aaskelund KJ, Chamley LW. (2011). Trophoblast deportation part 1: review of the evidence demonstrating trophoblast shedding and deportation during human pregnancy. Placenta, 32, 716–723. doi:10.1016/j.placenta.2011.07.081
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Chandel N, Jain V, Jha V. (2010). The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. J Hum Hypertens, 26(4), 236–241. doi:10.1038/jhh.2011.29
   Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. (2013). Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol, 122, 1122.
   PubMed Web of Science ®Google Scholar
• Baumann MU, Bersinger NA, Mohaupt MG, et al. (2008). First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 ats first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol, 199(3), 266. doi:10.1016/j.ajog.2008.06.069
   PubMed Web of Science ®Google Scholar
• Bell MJ, Roberts JM, Founds SA, et al. (2013). Variation in endoglin pathway genes is associated with preeclampsia: a case–control candidate gene association study. BMC Pregnancy Childbirth, 13(1), 82. doi:10.1186/1471-2393-13-174
   PubMedGoogle Scholar
• Bujold E, Roberge S, Lacasse Y, et al. (2010). Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol, 116, 402–414. doi:10.1097/AOG.0b013e3181e9322a
   PubMed Web of Science ®Google Scholar
• Contro E, Bernabini D, Farina A. (2017 Apr). Cell-free fetal DNA for the prediction of pre-eclampsia at the first and second trimesters: a systematic review and meta-analysis. Mol Diagn Ther, 21(2), 125–135. doi:10.1007/s40291-016-0245-9
   PubMed Web of Science ®Google Scholar
• Hagmann H, Thadhani R, Benzing T, et al. (2012). The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem, 58, 837–845. doi:10.1373/clinchem.2011.169094
   PubMed Web of Science ®Google Scholar
• Hahn S, Huppertz B, Holzgreve W. (2005 Aug). Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation?. Placenta, 26(7), 515–526. Epub 2004 Dec 23. doi:10.1016/j.placenta.2004.10.017
   PubMed Web of Science ®Google Scholar
• Lazar L, Rigó J, Nagy B, et al. (2009). Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med Genet, 10, 120. doi:10.1186/1471-2350-10-120
   PubMed Web of Science ®Google Scholar
• Lim JH, Kim SY, Park SY, et al. (2009). Soluble endoglin and transforming growth factorβ1 in women who subsequently developed preeclampsia. Prenat Diagn, 29(5), 471–476. doi:10.1002/pd.2217
   PubMed Web of Science ®Google Scholar
• López-Casillas F, Cheifetz S, Doody J, et al. (1991). Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell, 67, 785–795. doi:10.1016/0092-8674(91)90073-8
   PubMed Web of Science ®Google Scholar
• Mosbah A, Nabiel Y. (2016). Helicobacter pylori, Chlamydiae pneumoniae and trachomatis as probable etiological agents of preeclampsia. Maternal-Fetal & Neonatal Med, 29(10), 1607–1612. doi:10.3109/14767058.2015.1056146
   PubMed Web of Science ®Google Scholar
• Nikuei P, Rajaei M, Malekzadeh NA, et al. (2017 Sep). Accuracy of soluble endoglin for diagnosis of preeclampsia and its severity. Iran Biomed J, 21(5), 312–330.
   PubMedGoogle Scholar
• Papantoniou N, Bagiokos V, Agiannitopoulos K, et al. (2013 Jul). RASSF1A in maternal plasma as a molecular marker of preeclampsia. Prenat Diagn, 33(7), 682–687. doi:10.1002/pd.4093
   PubMed Web of Science ®Google Scholar
• Perucci LO, Gomes KB, Freitas LG, et al. (2014). Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLoS One, 9(5), e97632. doi:10.1371/journal.pone.0097632
   PubMed Web of Science ®Google Scholar
• Prakash J, Pandey LK, Singh AK, Kar B. (2006). Hypertension in pregnancy: hospital based study. J Assoc Physicians India, 54, 273–278.
   PubMedGoogle Scholar
• Preciado-Martínez E, García-Ruíz G, Flores-Espinosa P, et al. (2017). Progesterone suppresses the lipopolysaccharide-induced pro-inflammatory response in primary mononuclear cells isolated from human placental blood. Immunolo Invest, 47(2), 181–195. doi:10.1080/08820139.2017.1413112
   PubMed Web of Science ®Google Scholar
• Rădulescu C, Bacârea A, Huțanu A, et al. (2016). Placental growth factor, soluble fms-like tyrosine kinase 1, soluble endoglin, IL-6, and IL-16 as biomarkers in preeclampsia. Mediators Inflamm, 2016, 3027–3363.
   Google Scholar
• Rana S, Cerdeira AS, Wenger J, et al. (2012). Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS One, 7, 48259. doi:10.1371/journal.pone.0048259
   PubMed Web of Science ®Google Scholar
• Rokhafrooz S, Ghadiri A, Ghandil P, et al. (2018). Association between HLA-G 14bp gene polymorphism and serum sHLA-G protein concentrations in preeclamptic patients and normal pregnant women. Immunolo Invest, 47(6), 558–568. doi:10.1080/08820139.2018.1467925
   PubMed Web of Science ®Google Scholar
• Rusterholz C, Hahn S, Holzgreve W. (2007). Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol, 29, 151–162. doi:10.1007/s00281-007-0071-6
   PubMed Web of Science ®Google Scholar
• Sachan R, Patel ML, Dhiman S, et al. (2016 Jul). Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia. Adv Biomed Res, 29(5), 119. doi:10.4103/2277-9175.186993
   Google Scholar
• Sekizawa A, Jimbo M, Saito H, et al. (2003 Feb). Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol, 188(2), 480–484.
   PubMed Web of Science ®Google Scholar
• Shenoy V, Kanasaki K, Kalluri R. (2010). Pre-eclampsia: connecting angiogenic and metabolic pathways. Trends Endocrinol Metab, 21(9), 529–536. doi:10.1016/j.tem.2010.05.002
   PubMed Web of Science ®Google Scholar
• Sifakis S, Zaravinos A, Maiz N, et al. (2009 Nov). First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol, 201(5), 472.e1–7. doi:10.1016/j.ajog.2009.05.025
   PubMed Web of Science ®Google Scholar
• Silver RM, Myatt L, Hauth JC, et al. (2017 Jan). Cell-free total and fetal DNA in first trimester maternal serum and subsequent development of preeclampsia. Am J Perinatol, 34(2), 191–198. doi:10.1055/s-0035-1570383
   PubMed Web of Science ®Google Scholar
• Venkatesha S, Toporsian M, Lam C, et al. (2006). Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med, 12, 642–649. doi:10.1038/nm1429
   PubMed Web of Science ®Google Scholar
• Yu H, Shen Y, Ge Q, et al. (2013 Apr). Quantification of maternal serum cell-free fetal DNA in early-onset preeclampsia. Int J Mol Sci, 14(4), 7571–7582. doi:10.3390/ijms14047571
   PubMed Web of Science ®Google Scholar